Advancements in sequencing technologies have highlighted the role of alternative splicing (AS) in increasing transcriptome 10 complexity. This role of AS, combined with the relation of aberrant splicing to malignant states, motivated two streams of 11 research, experimental and computational. The first involves a myriad of techniques such as RNA-Seq and CLIP-Seq to 12 identify splicing regulators and their putative targets. The second involves probabilistic models, also known as splicing 13 codes, which infer regulatory mechanisms and predict splicing outcome directly from genomic sequence. To date, these 14 models have utilized only expression data. In this work we address two related challenges: Can we improve on previous 15 models for AS outcome prediction and can we integrate additional sources of data to improve predictions for AS regulatory 16 factors. We perform a detailed comparison of two previous modeling approaches, Bayesian and Deep Neural networks, 17 dissecting the confounding effects of datasets and target functions. We then develop a new target function for AS prediction 18 and show that it significantly improves model accuracy. Next, we develop a modeling framework to incorporate CLIP-Seq, 19 knockdown and over-expression experiments, which are inherently noisy and suffer from missing values. Using several 20 datasets involving key splice factors in mouse brain, muscle and heart we demonstrate both the prediction improvements 21 and biological insights offered by our new models. Overall, the framework we propose offers a scalable integrative solution 22 to improve splicing code modeling as vast amounts of relevant genomic data become available.
for smaller datasets. However, later work using a Deep Neural Network with an autoencoder demonstrated improved Table 10 ). Together, these datasets highlight some of the challenges involved in utilizing such diverse experiments. First, 83 CLIP-Seq experiments give noisy measurement of where a splice factor binds. The measurements are noisy since binding 84 signal (reads aligning to a certain area) may be false positives, may not indicate active regulation and may suffer from 85 false negatives due to low coverage, indirect binding, antibody sensitivity, etc. Moreover, these experiments are typically 86 executed by different labs, in different conditions and at varying levels of coverage. Thus, it is crucial that any learning 87 framework that we develop should be able to handle missing and noisy measurements. 88 In our learning setting, the CLIP-Seq data is turned to input features indicating possible binding in a region proximal 89 to the alternative exon (e.g. upstream intron). The target in our problem formulation is the relative exon inclusion level in 90 a given experiment, expressed as percent spliced in (PSI, Ψ ∈ [0, 1]). PSI serves to capture the proportion of isoforms that 91 include the exon versus those that skip it. But since these are not observed directly, the short sequencing reads are used to 92 construct a posterior beta distribution over PSI per exon P (Ψ e t ) ∼ β(α e t,1 , α e t,2 ). Similarly, when comparing two conditions sequence features will be penalized just the same, though there was no substantial evidence against it.
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In order to overcome the above limitations, for every pair of conditions c and c , we define three target variables:
where TΨ e,c is the expected PSI value of the event e in condition c. T∆Ψ 
